Corrigendum to “Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared in vivo imaging” [Biomater. 34 (2013)7143–7157](S0142961213006698)(10.1016/j.biomaterials.2013.05.077);Multifunctional calcium phosphate nano-contrast agent for combined nuclear, magnetic and near-infrared invivo imaging

Biomaterials

Volumn 34, Issue 29, 2013, Pages 7143-7157

  Ashokan, Anusha ^a   Gowd, Genekehal S ^a   Somasundaram, Vijay H ^a   Bhupathi, Arun ^a   Peethambaran, Reshmi ^a   Unni, A K K ^a   Palaniswamy, Shanmugasundaram ^a   Nair, Shantikumar V ^a   Koyakutty, Manzoor ^a  

^a AMRITA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

Calcium phosphate nanoparticles; Magnetic contrast; NIR contrast; Nuclear contrast; Tri modal invivo imaging

Indexed keywords

BLOOD; CALCIUM PHOSPHATE; DIAGNOSIS; INFRARED DEVICES; MAMMALS; NANOPARTICLES; THERMOGRAPHY (IMAGING);

CALCIUM PHOSPHATE NANOPARTICLES; IN-VIVO IMAGING; MAGNETIC CONTRAST; NIR CONTRAST; NUCLEAR CONTRAST;

NANOMAGNETICS;

CALCIUM PHOSPHATE NANOPARTICLE; CONTRAST MEDIUM; GADOLINIUM; INDOCYANINE GREEN; MEDRONIC ACID; NANOCONTRAST AGENT; NANOPARTICLE; POLYETHYLENEIMINE; TECHNETIUM 99M; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIAGNOSTIC IMAGING; FLUORESCENCE IMAGING; HISTOLOGY; IN VIVO STUDY; MONONUCLEAR CELL; MOUSE; NEAR INFRARED SPECTROSCOPY; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

MUS;

EID: 84879601932     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2019.05.017     Document Type: Erratum

References (67)

1. Moore A., Medarova Z., Potthast A., Dai G. Invivo targeting of underglycosylated MUC-1 tumor antigen using a multimodal imaging probe. Cancer Res 2004, 64:1821-1827.
2. Kircher M.F., Mahmood U., King R.S., Weissleder R., Josephson L. Amultimodal nanoparticle for preoperative magnetic resonance imaging and intraoperative optical brain tumor delineation. Cancer Res 2003, 63:8122-8125.
3. Josephson L., Kircher M.F., Mahmood U., Tang Y., Weissleder R. Near-infrared fluorescent nanoparticles as combined MR/optical imaging probes. Bioconjug Chem 2002, 13:554-560.
4. Cheng L., Yang K., Li Y., Zeng X., Shao M., Lee S.T., et al. Multifunctional nanoparticles for upconversion luminescence/MR multimodal imaging and magnetically targeted photothermal therapy. Biomaterials 2012, 33:2215-2222.
5. Bar-Shalom R., Yefremov N., Guralnik L., Gaitini D., Frenkel A., Kuten A., et al. Clinical performance of PET/CT in evaluation of cancer: additional value for diagnostic imaging and patient management. JNucl Med 2003, 44:1200-1209.
6. Israel O., Kuten A. Early detection of cancer recurrence: 18F-FDG PET/CT can make a difference in diagnosis and patient care. JNucl Med 2007, 48:28S-35.
7. Beyer T., Townsend D.W., Brun T., Kinahan P.E., Charron M., Roddy R., et al. Acombined PET/CT scanner for clinical oncology. JNucl Med 2000, 41:1369-1379.
8. Judenhofer M.S., Wehrl H.F., Newport D.F., Catana C., Siegel S.B., Becker M., et al. Simultaneous PET-MRI: a new approach for functional and morphological imaging. Nat Med 2008, 14:459-465.
9. Buchbender C., Heusner T.A., Lauenstein T.C., Bockisch A., Antoch G. Oncologic PET/MRI, part 1: tumors of the brain, head and neck, chest, abdomen, and pelvis. JNucl Med 2012, 53:928-938.
10. Becker A., Hessenius C., Licha K., Ebert B., Sukowski U., Semmler W., et al. Receptor-targeted optical imaging of tumors with near-infrared fluorescent ligands. Nat Biotechnol 2001, 19:327-331.
11. Xu H., Cheng L., Wang C., Ma X., Li Y., Liu Z. Polymer encapsulated upconversion nanoparticle/iron oxide nanocomposites for multimodal imaging and magnetic targeted drug delivery. Biomaterials 2011, 32:9364-9373.
12. Mulder W.J., Koole R., Brandwijk R.J., Storm G., Chin P.T., Strijkers G.J., et al. Quantum dots with a paramagnetic coating as a bimodal molecular imaging probe. Nano Lett 2006, 6:1-6.
13. Mitchell N., Kalber T.L., Cooper M.S., Sunassee K., Chalker S.L., Shaw K.P., et al. Incorporation of paramagnetic, fluorescent and PET/SPECT contrast agents into liposomes for multimodal imaging. Biomaterials 2013, 34:1179-1192.
14. Huang X., Zhang F., Lee S., Swierczewska M., Kiesewetter D.O., Lang L., et al. Long-term multimodal imaging of tumor draining sentinel lymph nodes using mesoporous silica-based nanoprobes. Biomaterials 2012, 33:4370-4378.
15. Jokerst J.V., Khademi C., Gambhir S.S. Intracellular aggregation of multimodal silica nanoparticles for ultrasound-guided stem cell implantation. Sci Transl Med 2013, 5:177ra35.
16. Selvan S.T., Patra P.K., Ang C.Y., Ying J.Y. Synthesis of silica-coated semiconductor and magnetic quantum dots and their use in the imaging of live cells. Angew Chem Int Ed Engl 2007, 46:2448-2452.
17. Derfus A.M., Chan W.C.W., Bhatia S.N. Probing the cytotoxicity of semiconductor quantum dots. Nano Lett 2004, 4:11-18.
18. Napierska D., Thomassen L.C., Rabolli V., Lison D., Gonzalez L., Kirsch-Volders M., et al. Size-dependent cytotoxicity of monodisperse silica nanoparticles in human endothelial cells. Small 2009, 5:846-853.
19. Avnir D., Levy D., Reisfeld R. The nature of the silica cage as reflected by spectral changes and enhanced photostability of trapped rhodamine 6G. JPhys Chem 1984, 88:5956-5959.
20. Edwards W.B., Akers W.J., Ye Y., Cheney P.P., Bloch S., Xu B., et al. Multimodal imaging of integrin receptor-positive tumors by bioluminescence, fluorescence, gamma scintigraphy, and single-photon emission computed tomography using a cyclic RGD peptide labeled with a near-infrared fluorescent dye and a radionuclide. Mol Imaging 2009, 8:101-110.
21. Bhushan K.R., Misra P., Liu F., Mathur S., Lenkinski R.E., Frangioni J.V. Detection of breast cancer microcalcifications using a dual-modality SPECT/NIR fluorescent probe. JAm Chem Soc 2008, 130:17648-17649.
22. Ogawa M., Regino C.A., Seidel J., Green M.V., Xi W., Williams M., et al. Dual-modality molecular imaging using antibodies labeled with activatable fluorescence and a radionuclide for specific and quantitative targeted cancer detection. Bioconjug Chem 2009, 20:2177-2184.
23. Edwards W.B., Xu B., Akers W., Cheney P.P., Liang K., Rogers B.E., et al. Agonist-antagonist dilemma in molecular imaging: evaluation of a monomolecular multimodal imaging agent for the somatostatin receptor. Bioconjug Chem 2008, 19:192-200.
24. Xie J., Chen K., Huang J., Lee S., Wang J., Gao J., et al. PET/NIRF/MRI triple functional iron oxide nanoparticles. Biomaterials 2010, 31:3016-3022.
25. Cai W., Wu Y., Chen K., Cao Q., Tice D.A., Chen X. Invitro and invivo characterization of 64Cu-labeled Abegrin, a humanized monoclonal antibody against integrin alpha v beta 3. Cancer Res 2006, 66:9673-9681.
26. Hwang do W., Ko H.Y., Lee J.H., Kang H., Ryu S.H., Song I.C., et al. Anucleolin-targeted multimodal nanoparticle imaging probe for tracking cancer cells using an aptamer. JNucl Med 2010, 51:98-105.
27. Na H.B., Song I.C., Hyeon T. Inorganic nanoparticles for MRI contrast agents. Adv Mater 2009, 21:2133-2148.
28. Zhou J., Yu M., Sun Y., Zhang X., Zhu X., Wu Z., et al. Fluorine-18-labeled Gd3+/Yb3+/Er3+ co-doped NaYF4 nanophosphors for multimodality PET/MR/UCL imaging. Biomaterials 2011, 32:1148-1156.
29. Altinoǧlu E.I., Russin T.J., Kaiser J.M., Barth B.M., Eklund P.C., Kester M., et al. Near-infrared emitting fluorophore-doped calcium phosphate nanoparticles for invivo imaging of human breast cancer. ACS Nano 2008, 2:2075-2084.
30. Mondejar S.P., Kovtuna A., Epple M. Lanthanide-doped calcium phosphate nanoparticles with high internal crystallinity and with a shell of DNA as fluorescent probes in cell experiments. JMater Chem 2007, 17:4153-4159.
31. Kester M., Heakal Y., Fox T., Sharma A., Robertson G.P., Morgan T.T., et al. Calcium phosphate nanocomposite particles for invitro imaging and encapsulated chemotherapeutic drug delivery to cancer cells. Nano Lett 2008, 8:4116-4121.
32. Neumann S., Kovtun A., Dietzel I.D., Epple M., Heumann R. The use of size-defined DNA-functionalized calcium phosphate nanoparticles to minimise intracellular calcium disturbance during transfection. Biomaterials 2009, 30:6794-6802.
33. Sokolova V., Kovtun A., Prymak O., Meyer-Zaika W., Kubareva E.A., Romanova E.A., et al. Functionalisation of calcium phosphate nanoparticles by oligonucleotides and their application for gene silencing. JMater Chem 2007, 17:721-727.
34. Dorozhkin S.V., Epple M. Biological and medical significance of calcium phosphates. Angew Chem Int Ed Engl 2002, 41:3130-3146.
35. He Q., Mitchell A.R., Johnson S.L., Wagner-Bartak C., Morcol T., Bell S.J. Calcium phosphate nanoparticle adjuvant. Clin Diagn Lab Immunol 2000, 7:899-903.
36. Barth B.M., Sharma R., Altinoǧlu E.I., Morgan T.T., Shanmugavelandy S.S., Kaiser J.M., et al. Bioconjugation of calcium phosphosilicate composite nanoparticles for selective targeting of human breast and pancreatic cancers invivo. ACS Nano 2010, 4:1279-1287.
37. Barth B.M., Altinoǧlu E., Shanmugavelandy S.S., Kaiser J.M., Crespo-Gonzalez D., DiVittore N.A., et al. Targeted indocyanine-green-loaded calcium phosphosilicate nanoparticles for invivo photodynamic therapy of leukemia. ACS Nano 2011, 5:5325-5337.
38. Ashokan A., Menon D., Nair S., Koyakutty M. Amolecular receptor targeted, hydroxyapatite nanocrystal based multi-modal contrast agent. Biomaterials 2010, 31:2606-2616.
39. Chen F., Huang P., Zhu Y.J., Wu J., Cui D.X. Multifunctional Eu3+/Gd3+ dual-doped calcium phosphate vesicle-like nanospheres for sustained drug release and imaging. Biomaterials 2012, 33:6447-6455.
40. Chen F., Huang P., Zhu Y.J., Wu J., Zhang C.L., Cui D.X. The photoluminescence, drug delivery and imaging properties of multifunctional Eu3+/Gd3+ dual-doped hydroxyapatite nanorods. Biomaterials 2011, 32:9031-9039.
41. Ashokan A., Chandran P., Sadanandan A.R., Koduri C.K., Retnakumari A.P., Menon D., et al. Development and haematotoxicological evaluation of doped hydroxyapatite based multimodal nanocontrast agent for near-infrared, magnetic resonance and X-ray contrast imaging. Nanotoxicology 2012, 6:652-666.
42. Hu Y.Y., Rawal A., Schmidt-Rohr K. Strongly bound citrate stabilizes the apatite nanocrystals in bone. Proc Natl Acad Sci USA 2010, 107:22425-22429.
43. Xie B., Nancollas G.H. How to control the size and morphology of apatite nanocrystals in bone. Proc Natl Acad Sci USA 2010, 107:22369-22370.
44. Cherrick G.R., Stein S.W., Leevy C.M., Davidson C.S. Indocyanine green: observations on its physical properties, plasma decay, and hepatic extraction. JClin Invest 1960, 39:592-600.
45. Ntziachristos V., Yodh A.G., Schnall M., Chance B. Concurrent MRI and diffuse optical tomography of breast after indocyanine green enhancement. Proc Natl Acad Sci USA 2000, 97:2767-2772.
46. Landsman M.L., Kwant G., Mook G.A., Zijlstra W.G. Light-absorbing properties, stability, and spectral stabilization of indocyanine green. JAppl Physiol 1976, 40:575-583.
47. Saxena V., Sadoqi M., Shao J. Enhanced photo-stability, thermal-stability and aqueous-stability of indocyanine green in polymeric nanoparticulate systems. JPhotochem Photobiol B 2004, 74:29-38.
48. Saxena V., Sadoqi M., Shao J. Polymeric nanoparticulate delivery system for Indocyanine green: biodistribution in healthy mice. Int J Pharm 2006, 308:200-204.
49. Lee C.H., Cheng S.H., Wang Y.J., Chen Y.C., Chen N.T., Souris J., et al. Near-Infrared mesoporous silica nanoparticles for optical imaging: characterization and invivo biodistribution. Adv Funct Mater 2009, 19:215-222.
50. Shkilnyy A., Friedrich A., Tiersch B., Schöne S., Fechner M., Koetz J., et al. Poly(ethylene imine)-controlled calcium phosphate mineralization. Langmuir 2008, 24:2102-2109.
51. Yeh C.S., Su C.H., Ho W.Y., Huang C.C., Chang J.C., Chien Y.H., et al. Tumor targeting and MR imaging with lipophilic cyanine-mediated near-infrared responsive porous Gd silicate nanoparticles. Biomaterials 2013, 34:5677-5688.
52. Brooks R.A., Moiny F., Gillis P. On T2-shortening by weakly magnetized particles: the chemical exchange model. Magn Reson Med 2001, 45:1014-1020.
53. Hope T.A., Herfkens R.J., Denianke K.S., LeBoit P.E., Hung Y.Y., Weil E. Nephrogenic systemic fibrosis in patients with chronic kidney disease who received gadopentetate dimeglumine. Invest Radiol 2009, 44:135-139.
54. Even-Sapir E., Martin R.H., Barnes D.C., Pringle C.R., Iles S.E., Mitchell M.J. Role of SPECT in differentiating malignant from benign lesions in the lower thoracic and lumbar vertebrae. Radiology 1993, 187:193-198.
55. Flanagan A.M., Chambers T.J. Inhibition of bone resorption by bisphosphonates: interactions between bisphosphonates, osteoclasts, and bone. Calcif Tissue Int 1991, 49:407-415.
56. Love C., Din A.S., Tomas M.B., Kalapparambath T.P., Palestro C.J. Radionuclide bone imaging: an illustrative review. Radiographics 2003, 23:341-358.
57. Santos M.F., Furtado R.N., Konai M.S., Castiglioni M.L., Marchetti R.R., Natour J. Effectiveness of radiation synovectomy with samarium-153 particulate hydroxyapatite in rheumatoid arthritis patients with knee synovitis: a controlled randomized double-blind trial. Clinics 2009, 64:1187-1193.
58. Mayer A., Vadon M., Rinner B., Novak A., Wintersteiger R., Fröhlich E. The role of nanoparticle size in hemocompatibility. Toxicology 2009, 258:139-147.
59. Tiwari D.K., Jin T., Behari J. Dose-dependent in-vivo toxicity assessment of silver nanoparticle in Wistar rats. Toxicol Mech Methods 2011, 21:13-24.
60. Jevprasesphant R., Penny J., Jalal R., Attwood D., McKeown N.B., D'Emanuele A. The influence of surface modification on the cytotoxicity of PAMAM dendrimers. Int J Pharm 2003, 252:263-266.
61. Wang W., Xiong W., Zhu Y., Xu H., Yang X. Protective effect of PEGylation against poly(amidoamine) dendrimer-induced hemolysis of human red blood cells. JBiomed Mater Res B Appl Biomater 2010, 93:59-64.
62. Chen B.X., Wilson S.R., Das M., Coughlin D.J., Erlanger B.F. Antigenicity of fullerenes: antibodies specific for fullerenes and their characteristics. Proc Natl Acad Sci USA 1998, 95:10809-10813.
63. Radomski A., Jurasz P., Alonso-Escolano D., Drews M., Morandi M., Malinski T., et al. Nanoparticle-induced platelet aggregation and vascular thrombosis. Br J Pharmacol 2005, 146:882-893.
64. Miller V.M., Hunter L.W., Chu K., Kaul V., Squillace P.D., Lieske J.C., et al. Biologic nanoparticles and platelet reactivity. Nanomedicine (Lond) 2009, 4:725-733.
65. Semberova J., De Paoli Lacerda S.H., Simakova O., Holada K., Gelderman M.P., Simak J. Carbon nanotubes activate blood platelets by inducing extracellular Ca2+ influx sensitive to calcium entry inhibitors. Nano Lett 2009, 9:3312-3317.
66. Gabizon A., Catane R., Uziely B., Kaufman B., Safra T., Cohen R., et al. Prolonged circulation time and enhanced accumulation in malignant exudates of doxorubicin encapsulated in polyethylene-glycol coated liposomes. Cancer Res 1994, 54:987-992.
67. Lu J., Descamps M., Dejou J., Koubi G., Hardouin P., Lemaitre J., et al. The biodegradation mechanism of calcium phosphate biomaterials in bone. JBiomed Mater Res 2002, 63:408-412.